- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07158515
- Original Trial
The Heart Health After Cardiac Treatment Study (HEART-ACT)
September 16, 2025 updated by: Alexis Beatty, MD, University of California, San Francisco
The goal of this study is to determine whether participation in a tailored cardiac rehabilitation program delivered in a safety net setting, compared to usual care referral to an outside cardiac rehabilitation program, results in greater participation in cardiac rehabilitation.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alisa Boyd, MPH
- Phone Number: 415-514-7905
- Email: heartact@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94110
- Recruiting
- Zuckerberg San Francisco General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18+
Referred for cardiac rehabilitation for a covered indication:
- Acute myocardial infarction
- Percutaneous coronary intervention
- Coronary artery bypass surgery
- Heart valve repair or replacement
- Heart transplant
- Chronic stable angina
- Chronic systolic heart failure (EF <=35%)
- Able to communicate in English, Spanish, or Cantonese
- Able to consent for self
Exclusion Criteria:
- Currently enrolled in hospice.
- Provider says patient may not be approached for participation in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tailored cardiac rehabilitation in a safety net setting
A 12-week program of exercise training and health behavior counseling consisting of every other week group sessions (exercise and health behavior education) and every other week individual counseling sessions that address the cardiac rehabilitation core components.
|
The program will address the core components of CR.21
Each of the program components will have an individualized assessment with plan and goals set at the program intake visit.
The 12-week program will alternate between group and individual sessions each week.
Individualized plans will be reviewed every two weeks at the participant individual sessions.
Group sessions will address physical activity, nutrition, and other program topics.
Duration of the program was chosen to resemble a typical 12-week cardiac rehabilitation intervention.
However, the program will have a greater emphasis on cultural tailoring, language concordance, lowering burden of real-time in-person attendance, motivational coaching, and addressing psychosocial needs.
|
|
Active Comparator: Referral to an outside cardiac rehabilitation program
Referral to a cardiac rehabilitation program outside of the safety net hospital setting.
|
Participants will be referred to an external cardiac rehabilitation program outside of the safety net setting.
This is the current standard of care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participation in at least 1 session of cardiac rehabilitation
Time Frame: 12 months
|
In each arm, the proportion of participants who attended at least 1 cardiac rehabilitation session will be calculated.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in six-minute walk distance
Time Frame: 12 months
|
Change in distance walked in 6 minutes, following a standard protocol, from baseline to 12 months.
|
12 months
|
|
Change in six-minute walk distance
Time Frame: 3 months
|
Change in distance walked in 6 minutes, following a standard protocol, from baseline to 3 months.
|
3 months
|
|
Completion of cardiac rehabilitation
Time Frame: 12 months
|
In each arm, the proportion of participants who attend at least 2/3 of expected sessions of cardiac rehabilitation (24 sessions in the active comparator arm and 8 sessions in the experimental arm) will be calculated.
|
12 months
|
|
Change in quality of life
Time Frame: 12 months
|
Change in PROMIS Global Health physical and mental subscores between baseline and 12 months.
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The physical and mental health subscales each consist of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better physical health.
|
12 months
|
|
Change in quality of life
Time Frame: 3 months
|
Change in PROMIS Global Health physical and mental subscores between baseline and 3 months.
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The physical and mental health subscales each consist of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better physical health.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Alexis Beatty, MD, MAS, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 28, 2023
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
August 28, 2025
First Submitted That Met QC Criteria
August 28, 2025
First Posted (Estimated)
September 5, 2025
Study Record Updates
Last Update Posted (Estimated)
September 18, 2025
Last Update Submitted That Met QC Criteria
September 16, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 23-40216
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
At the conclusion of the study, we will follow local procedures and laws regarding the sharing of individual participant data.
Any data that are shared will be de-identified prior to sharing.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Rehabilitation
-
Pakistan Institute of Medical SciencesNot yet recruiting
-
Mayo ClinicRecruitingCardiac RehabilitationUnited States
-
I.R.C.C.S. Fondazione Santa LuciaUniversity of Roma La SapienzaCompleted
-
Defactum, Central Denmark RegionCompleted
-
Ivy susanne Modrau, MDAalborg University HospitalEnrolling by invitationCardiac RehabilitationDenmark
-
University of Central LancashireUniversity of Hull; Sheffield Hallam University; Leeds Beckett UniversityWithdrawnCardiac RehabilitationUnited Kingdom
-
University of North Carolina, Chapel HillNational Institutes of Health (NIH)CompletedCardiac RehabilitationUnited States
-
Shanghai Zhongshan HospitalNot yet recruiting
-
University of ValenciaActive, not recruitingCardiac RehabilitationSpain
-
Texas A&M UniversityAscension HealthActive, not recruiting
Clinical Trials on Tailored cardiac rehabilitation
-
Helsinki University Central HospitalRecruitingPost Covid-19 ConditionFinland
-
Wake Forest University Health SciencesRecruitingCardiac AmyloidosisUnited States
-
Lawson Health Research InstituteHeart and Stroke Foundation of OntarioCompleted
-
Atlas UniversityCompletedCoronary Artery Disease | Coronary Artery Bypass Graft SurgeryTurkey (Türkiye)
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); AstraZenecaCompletedMyocardial Infarction | Coronary Disease | Unstable AnginaCanada
-
Cairo UniversityNational Heart Institute, EgyptCompletedChronic Heart FailureEgypt
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Heart DiseaseUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; Johns Hopkins University; Mayo... and other collaboratorsRecruitingMyocardial Infarction | Coronary Artery Disease | Heart Valve Diseases | Angina, Stable | Heart Failure, Systolic | Heart TransplantUnited States
-
Federico II UniversityCompletedAcute Myocardial InfarctionItaly
-
Samsung Medical CenterCompletedCongenital Heart DiseaseKorea, Republic of